Suzhou Basecare Medical (HKSE:02170) Other Stockholders Equity: HK$2.1 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02170 Suzhou Basecare Medical Corp Ltd HKSE:02170
68 GF Score
Price HK$1.36
GF Value HK$2.96
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Suzhou Basecare Medical Other Stockholders Equity?

Suzhou Basecare Medical HKSE:02170 +1.49% 68 Other Stockholders Equity is HK$2.1 Mil as of Dec. 2025. GuruFocus rates HKSE:02170 with a GF Score™ of 68/100 and a GF Value™ of HK$2.96 (Possible Value Trap). The stock has 7 warning signs investors should review.

Suzhou Basecare Medical's Other Stockholders Equity for the quarter that ended in Dec. 2025 was HK$2.1 Mil.

Suzhou Basecare Medical's quarterly Other Stockholders Equity increased from Dec. 2024 (HK$-14.0 Mil) to Jun. 2025 (HK$-1.9 Mil) and increased from Jun. 2025 (HK$-1.9 Mil) to Dec. 2025 (HK$2.1 Mil).

Suzhou Basecare Medical's annual Other Stockholders Equity declined from Dec. 2023 (HK$6.5 Mil) to Dec. 2024 (HK$-14.0 Mil) but then increased from Dec. 2024 (HK$-14.0 Mil) to Dec. 2025 (HK$2.1 Mil).

Suzhou Basecare Medical Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Suzhou Basecare Medical's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Basecare Medical Other Stockholders Equity Chart

Suzhou Basecare Medical Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 9.68 8.83 6.52 -14.00 2.14

Suzhou Basecare Medical Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.52 0.44 -14.00 -1.92 2.14
HKSE:02170
68GF Score
Suzhou Basecare Medical Corp Ltd HKSE:02170
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Suzhou Basecare Medical Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of HK$2.1 Mil mean?
Suzhou Basecare Medical (HKSE:02170) has a Other Stockholders Equity of HK$2.1 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Suzhou Basecare Medical and its competitors.
Is Suzhou Basecare Medical's Other Stockholders Equity too high?
Suzhou Basecare Medical's current Other Stockholders Equity is HK$2.1 Mil. Overall, Suzhou Basecare Medical has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Suzhou Basecare Medical's Other Stockholders Equity compare to ABT and SYK?
Suzhou Basecare Medical's Other Stockholders Equity of HK$2.1 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Devices & Instruments company?
A good Other Stockholders Equity depends on the Medical Devices & Instruments industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Suzhou Basecare Medical and its competitors. Suzhou Basecare Medical's current Other Stockholders Equity is HK$2.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Suzhou Basecare Medical stock overvalued right now?
Based on GuruFocus' analysis, Suzhou Basecare Medical (HKSE:02170) is currently considered Possible Value Trap. The stock's GF Value™ is HK$2.96, compared to a current price of HK$1.36 — trading 54.1% below its estimated fair value. The current Other Stockholders Equity is HK$2.1 Mil. Suzhou Basecare Medical's overall GF Score™ is 68/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Suzhou Basecare Medical (HKSE:02170), the current Other Stockholders Equity is HK$2.1 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Suzhou Basecare Medical (HKSE:02170) Overvalued in 2026?

Based on GuruFocus' analysis, Suzhou Basecare Medical stock appears to be undervalued. The current stock price of HK$1.36 is trading 54.1% below its estimated GF Value™ of HK$2.96. GuruFocus considers Suzhou Basecare Medical to be Possible Value Trap.

Key valuation signals for HKSE:02170:

  • Other Stockholders Equity: HK$2.1 Mil
  • GF Value™: HK$2.96 vs. price of HK$1.36 (54.1% below fair value)
  • GF Score™: 68/100 with 7 warning signs

No single metric tells the full story. See the HKSE:02170 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Suzhou Basecare Medical Business Description

Address No. 77 Jingu Road, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN
Suzhou Basecare Medical Corp Ltd is a medical device company based in China, operating in the field of assisted reproduction. It is engaged in the research, development, and provision of medical products and related software in the field of reproductive health, to enable more families to have children. The Group's product portfolio comprises Gems Sperm Wash Gradient Set, Gems Fertilisation Medium, Gavi Instrument, Geri Incubator, Cryostorage System, PGT-A kit, Self sperm testing device, Sperm quality analyser, Genie sequencer, and others. It generates maximum revenue from the sale of testing kits. The Group's reportable segments are: the PRC, which derives maximum revenue, and Australia. Geographically, it operates in the PRC, Europe, Asia (excluding the PRC), and other regions.
68GF Score

Get the complete analysis for HKSE:02170

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$1.36
Price
HK$2.96
GF Value